Nierenberg Investment Management Company, Inc. Cytom X Therapeutics, Inc. Transaction History
Nierenberg Investment Management Company, Inc.
- $180 Million
- Q4 2024
A detailed history of Nierenberg Investment Management Company, Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Nierenberg Investment Management Company, Inc. holds 12,555 shares of CTMX stock, worth $7,407. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,555
Previous 12,555
-0.0%
Holding current value
$7,407
Previous $14,000
14.29%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CTMX
# of Institutions
71Shares Held
46.1MCall Options Held
3.7KPut Options Held
4.7K-
Tang Capital Management LLC San Diego, CA7.31MShares$4.31 Million0.57% of portfolio
-
Bvf Inc San Francisco, CA5.23MShares$3.08 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.16MShares$3.05 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX3.91MShares$2.3 Million1.19% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.22MShares$1.9 Million0.0% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $38.9M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...